Showing results (61-70 of 233) with videos related to
Sort By:
Pageof 24
General Pharmacology|September 7, 2000
Role of the postsynaptic alpha(2)-adrenergic receptor subtypes in catecholamine-induced vasoconstrictionI Duka, I Gavras, C Johns, et al.Circulation Research|August 1, 1981
Blood pressure response to central and/or peripheral inhibition of phenylethanolamine N-methyltransferase in normotensive and hypertensive ratsJ Black, B Waeber, M R Bresnahan, et al.Journal of Cardiovascular Pharmacology|November 1, 1982
Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockadeJ Biollaz, H R Brunner, I Gavras, et al.Hypertension (Dallas, Tex. : 1979)|February 1, 1992
Inhibition of nitric oxide, bradykinin, and prostaglandins in normal ratsY X Wang, I Gavras, T Wierzba, et al.The Journal of Pharmacy and Pharmacology|January 1, 1991
Two highly effective V1/V2 antagonists of vasopressin containing novel thioacids at position 1B Lammek, Y X Wang, R Franco, et al.Hypertension (Dallas, Tex. : 1979)|December 1, 1996
Models of experimental hypertension in miceC Johns, I Gavras, D E Handy, et al.Transactions of the Association of American Physicians|January 1, 1978
Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertensionA V Chobanian, H Gavras, J C Melby, et al.American Journal of Hypertension|September 30, 1998
Renal artery clipping attenuates the progression of adriamycin nephropathyA L Balbi, R J Franco, P Barretti, et al.Circulation Research|February 17, 2001
Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertensionI Duka, E Kintsurashvili, I Gavras, et al.Journal of Clinical Pharmacology|February 1, 1981
Effect of pindolol on blood pressure, plasma renin activity, and catecholamines in hypertensive patientsI Gavras, H Gavras, C P Tifft, et al.Pageof 24